Dr Lal PathLabs preps $95m India IPO
fivepointsix - Fotolia
India’s Dr Lal PathLabs has firmed up terms for its Rp6.32bn ($95m) IPO, with the small size of the transaction giving leads the confidence of a positive response when the deal launches.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts